Vericel targets $316M-$326M revenue in 2026 amid MACI sales force expansion and accelerating MACI Arthro adoption
Source: SeekingAlpha
2026-02-26 12:59:03 ET
More on Vericel
- Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript
- Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Vericel Corporation (VCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Vericel Q4 2025 Earnings Preview
- Vericel expects $276 mln revenue in 2025
Read the full article on Seeking Alpha
For further details see:
Vericel targets $316M–$326M revenue in 2026 amid MACI sales force expansion and accelerating MACI Arthro adoption
Vericel Corporation
NASDAQ: VCEL
VCEL Trading
-2.1% G/L:
$32.865 Last:
158,259 Volume:
$33.89 Open:
VCEL Latest News
March 04, 2026 08:00:00 am
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
VCEL Stock Data
$1,790,320,520
46,932,696
0.13%
97
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
